Page last updated: 2024-08-24

capecitabine and Anterior Horn Cell Disease

capecitabine has been researched along with Anterior Horn Cell Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanssen, H; Heldmann, M; Münte, TF; Wagner-Altendorf, TA1
Bergin, P; Damianovich, D; Findlay, M; Hanning, F; Hill, A; McKeage, MJ; Thompson, P1

Other Studies

2 other study(ies) available for capecitabine and Anterior Horn Cell Disease

ArticleYear
Permanent lesion to the corticospinal tract after therapy with capecitabine.
    BMJ case reports, 2019, Sep-18, Volume: 12, Issue:9

    Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Diagnosis, Differential; Fatal Outcome; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Middle Aged; Motor Neuron Disease; Pneumonia, Aspiration; Pyramidal Tracts; Quadriplegia

2019
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
    BMC cancer, 2010, Aug-23, Volume: 10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Motor Neuron Disease; Neoplasm Staging; Neurophysiology; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome

2010